Name | 3-Chloro-4-nitro-N-(5-nitro-1,3-thiazol-2-yl)benzamide |
---|---|
Synonyms |
NF-kappaB Activation Inhibitor III
SM-7368 3-Chloro-4-nitro-N-(5-nitro-2-thiazolyl)-benzamide Benzamide,3-chloro-4-nitro-N-(5-nitro-2-thiazolyl) 3-Chloro-4-nitro-N-(5-nitro-2-thiazolyl)-benzamide,SM 7368 |
Description | SM-7368 is a potent NF-kB inhibitor that targets downstream of MAPK p38 activation[1]. SM-7368 inhibits TNF-α-induced MMP-9 upregulation. SM-7368 can be used for the research of chemotherapies targeting TNF-α-mediated tumor invasion and metastasis [2]. |
---|---|
Related Catalog | |
Target |
NF-κB MMP-9 p38 MAP kinase |
In Vitro | SM-7368 (5 μM) targets downstream of MAPK p38 activation in the human colon derived crypt like HT-29 and Caco-2 epithelial cell lines[1]. SM-7368 inhibits TNF-α-induced MMP-9 upregulation in a concentration-dependent manner and shows maximal activity at 10 μM. SM-7368 inhibits TNF-α-induced MMP-9 mRNA transcript accumulation and protein expression. SM-7368 strongly inhibits TNF-α-induced NF-κB activity but not AP-1 activity. SM-7368 strongly inhibits the TNF-α-induced invasion of HT1080 human fibrosarcoma cell line[2]. SM-7368 (10-25 μM) greatly inhibits TNF-α (20 ng/mL)-induced MMP-9 upregulation. 10 μM of SM-7368 almost completely abrogates this upregulation[2]. Western Blot Analysis[2] Cell Line: HT1080 human fibrosarcoma cells Concentration: 0, 1, 5, 10, 15, 20, and 25 μM Incubation Time: 24 hours Result: Greatly inhibited TNF-α (20 ng/mL)-induced MMP-9 upregulation in a concentration-dependent manner. |
References |
Molecular Formula | C10H5ClN4O5S |
---|---|
Molecular Weight | 328.68900 |
Exact Mass | 327.96700 |
PSA | 165.36000 |
LogP | 4.29560 |
Symbol |
GHS05, GHS07 |
---|---|
Signal Word | Danger |
Hazard Statements | H302-H318 |
Precautionary Statements | P280-P305 + P351 + P338 |
Hazard Codes | Xi |
RIDADR | NONH for all modes of transport |